GAD-IgG-inducing CD4+Foxp3+Treg Cells Suppressing Diabetes Are Involved in the Increasing Ratio of CD80+:CD86+ Cells in NOD Mice

Archives of Medical Research

Volumn 39, Issue 3, 2008, Pages 299-305

  Wang, Renxi ^a   Han, Gencheng ^a   Wang, Jianan ^a   Song, Lun ^a   Chen, Guojiang ^a   Xu, Ruonan ^a   Zhang, Chunmei ^a,b   Yu, Ming ^a   Qian, Jiahua ^c   Shen, Beifen ^a   Li, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HENAN UNIVERSITY   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CD4+Foxp3+Treg cells; CD80; CD86; Diabetes; Foxp3; NOD mice

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN G; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; FEMALE; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T CELL DEPLETION;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; DIABETES MELLITUS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLUTAMATE DECARBOXYLASE; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; MICE; MICE, INBRED NOD; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 39149128271     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.11.007     Document Type: Article

References (17)

1. Song L., Wang J., Wang R., Yu M., Sun Y., Han G., et al. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?. Gene Ther 11 (2004) 1487-1496
2. Wang R., Song L., Han G., Wang J., Chen G., Xu R., et al. Mechanisms of regulatory T cell induction by antigen-IgG-transduced splenocytes. Scand J Immunol 66 (2007) 515-522
3. Bour-Jordan H., Salomon B.L., Thompson H.L., Szot G.L., Bernhard M.R., and Bluestone J.A. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J Clin Invest 114 (2004) 979-987
4. Arreaza G.A., Cameron M.J., Jaramillo A., Gill B.M., Hardy D., Laupland K.B., et al. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. J Clin Invest 100 (1997) 2243-2253
5. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu Rev Immunol 23 (2005) 515-548
6. Zheng Y., Manzotti C.N., Liu M., Burke F., Mead K.I., and Sansom D.M. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol 172 (2004) 2778-2784
7. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
8. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4 (2003) 337-342
9. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
10. Litzinger M.T., Su Y., Lei T.C., Soukhareva N., and Scott D.W. Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction. J Immunol 175 (2005) 780-787
11. Lenschow D.J., Ho S.C., Sattar H., Rhee L., Gray G., Nabavi N., et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181 (1995) 1145-1155
12. Lohr J., Knoechel B., Kahn E.C., and Abbas A.K. Role of B7 in T cell tolerance. J Immunol 173 (2004) 5028-5035
13. Salomon B., Rhee L., Bour-Jordan H., Hsin H., Montag A., Soliven B., et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 194 (2001) 677-684
14. Xystrakis E., Dejean A.S., Bernard I., Druet P., Liblau R., Gonzalez-Dunia D., et al. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104 (2004) 3294-3301
15. Chatenoud L., Salomon B., and Bluestone J.A. Suppressor T cells-they're back and critical for regulation of autoimmunity!. Immunol Rev 182 (2001) 149-163
16. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
17. Goleva E., Cardona I.D., Ou L.S., and Leung D.Y. Factors that regulate naturally occurring T regulatory cell-mediated suppression. J Allergy Clin Immunol 116 (2005) 1094-1100